We are live on
!
Find out more
Antipodes Partners Portfolio holdings
AUM
$5.46B
Turnover
36.94%
1-Year Est. Return
26.64%
This Fund
S&P 500
This Quarter
Est. Return
+5.97%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$4.76B
AUM Growth
+$305M
(+6.8%)
Cap. Flow
+$54.5M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
37.47%
Holding
149
New
33
Increased
46
Reduced
42
Closed
19
Avg Time Held Equity + Options
0.9
years
Top 10 Avg Time Held Equity + Options
1.7
years
Top 20 Avg Time Held Equity + Options
1.7
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$120M |
| 2 |
TotalEnergies
TTE
|
+$87.9M |
| 3 |
Amazon
AMZN
|
+$68.8M |
| 4 |
Microsoft
MSFT
|
+$58.4M |
| 5 |
Oracle
ORCL
|
+$57.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$153M |
| 2 |
Advanced Micro Devices
AMD
|
+$90.6M |
| 3 |
Johnson Controls International
JCI
|
+$82.5M |
| 4 |
Alcon
ALC
|
+$48.2M |
| 5 |
Barrick Mining
B
|
+$43.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 25.97% |
| 2 | Technology | 13.9% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 8.66% |
| 5 | Consumer Discretionary | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Bruker
BRKR
$8.61B
| $620K | 0.01% |
13,150
+4,982
| +61% | +$211K |
2025 Q1
3 quarters
|
|
77
CALL
Honeywell
HON
$66.7B
| $604K | 0.01% |
+2,067
| New | +$404K |
2025 Q4
0 quarters
|
|
78
Fermi Inc
FRMI
$2.18B
| $465K | 0.01% |
+58,160
| New | +$1.13M |
2025 Q4
0 quarters
|
|
79
Magnite
MGNI
$3.51B
| $403K | 0.01% |
+24,831
| New | +$412K |
2025 Q4
0 quarters
|
|
80
monday.com
MNDY
$3.99B
| $351K | 0.01% |
2,381
+1,078
| +83% | +$182K |
2025 Q3
1 quarter
|
|
81
Sweetgreen
SG
$1.26B
| $351K | 0.01% |
+51,873
| New | +$357K |
2025 Q4
0 quarters
|
|
82
Tidewater
TDW
$3.94B
| $277K | 0.01% |
5,485
+2,123
| +63% | +$112K |
2025 Q3
1 quarter
|
|
83
Lineage Inc
LINE
$7.77B
| $236K | ﹤0.01% |
+6,729
| New | +$249K |
2025 Q4
0 quarters
|
|
|
84
Johnson Controls International
JCI
$89.4B
| $209K | ﹤0.01% |
1,748
-718,892
| -100% | -$82.5M |
2023 Q1
11 quarters
|
|
85
Schrodinger
SDGR
$1.91B
| $205K | ﹤0.01% |
11,464
+6,552
| +133% | +$124K |
2025 Q1
3 quarters
|
|
86
Clipper Realty
CLPR
$51.5M
| $202K | ﹤0.01% |
+52,758
| New | +$197K |
2025 Q4
0 quarters
|
|
87
Immunome
IMNM
$2.05B
| $190K | ﹤0.01% |
8,834
-2,058
| -19% | -$36.1K |
2025 Q1
3 quarters
|
|
88
argenx
ARGX
$53.2B
| $165K | ﹤0.01% |
196
-91
| -32% | -$77.9K |
2022 Q4
12 quarters
|
|
89
Stryker
SYK
$112B
| $101K | ﹤0.01% |
288
+197
| +216% | +$71.8K |
2025 Q3
1 quarter
|
|
90
Avista
AVA
$3.03B
| $92K | ﹤0.01% |
+2,388
| New | +$93.3K |
2025 Q4
0 quarters
|
|
91
Steris
STE
$21.9B
| $89.2K | ﹤0.01% |
352
| – | – |
2025 Q1
3 quarters
|
|
92
Cencora
COR
$65.2B
| $82.8K | ﹤0.01% |
245
-21
| -8% | -$7.16K |
2025 Q2
2 quarters
|
|
93
Qiagen
QGEN
$9.53B
| $77.5K | ﹤0.01% |
1,637
+111
| +7% | +$5.13K |
2025 Q1
3 quarters
|
|
94
Thermo Fisher Scientific
TMO
$258B
| $75.9K | ﹤0.01% |
131
+33
| +34% | +$18.7K |
2025 Q3
1 quarter
|
|
95
Natera
NTRA
$58.3B
| $75.6K | ﹤0.01% |
330
| – | – |
2025 Q1
3 quarters
|
|
96
Regeneron Pharmaceuticals
REGN
$82B
| $74.9K | ﹤0.01% |
+97
| New | +$65.9K |
2025 Q4
0 quarters
|
|
97
Establishment Labs
ESTA
$1.83B
| $70.6K | ﹤0.01% |
969
-338
| -26% | -$20.4K |
2025 Q1
3 quarters
|
|
98
Medtronic
MDT
$122B
| $70.1K | ﹤0.01% |
+730
| New | +$70.9K |
2025 Q4
0 quarters
|
|
99
Gilead Sciences
GILD
$195B
| $68.4K | ﹤0.01% |
+557
| New | +$67.7K |
2025 Q4
0 quarters
|
|
100
MYR Group
MYRG
$4.45B
| $68K | ﹤0.01% |
311
+10
| +3% | +$2.18K |
2024 Q2
6 quarters
|
|
Similar funds
SCM
Antipodes Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Antipodes Partners held 149 positions worth $4.76B, up 6.8% from $4.46B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Antipodes Partners's Q4 2025 filing shows 33 new, 46 increased, 42 reduced and 19 closed positions. Its largest new stake was Meta Platforms (Facebook): 179,243 shares worth $118M. The largest sale was Alphabet (Google) Class A, an estimated $153M.
By sector, the portfolio is most concentrated in Utilities at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.
- Antipodes Partners's largest Q4 2025 buy was Meta Platforms (Facebook): 179,243 shares worth $118M.
- Antipodes Partners added most to Amazon in Q4 2025, an estimated $68.8M increase.
- Antipodes Partners's biggest Q4 2025 reduction was Advanced Micro Devices, cutting an estimated $90.6M.
- Antipodes Partners fully exited Alphabet (Google) Class A in Q4 2025, selling an estimated $153M.
- Antipodes Partners's ten largest holdings make up 37% of its $4.76B portfolio in Q4 2025.
- Antipodes Partners opened 33 new positions and closed 19 in Q4 2025.
- Antipodes Partners's portfolio value rose 6.8% quarter-over-quarter to $4.76B.
Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.